- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0033758

Aritas Pharmaceuticals Private Limited
About Aritas Pharmaceuticals Private Limited
Data last updated:
Aritas Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 07 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2021PTC144755.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Shavlesh Kumar Ravi and Beauty Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C12 – 0105 Supertech Eco Village 2 Gh – 01 Sec – 16B Greater Noida, Uttar Pradesh, India – 201318.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.3 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹21,416 (net margin 1.2%) and EBITDA of ₹73,642 (EBITDA margin 4.3%).
Aritas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0033758).
Company details
Recognitions & Rankings of Aritas Pharmaceuticals
Contact details
Aritas Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressC12 – 0105 Supertech Eco Village 2 Gh – 01 Sec – 16B Greater Noida, Uttar Pradesh, India – 201318
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aritas Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Aritas Pharmaceuticals Private Limited, buy the company report.
Financials of Aritas Pharmaceuticals Private Limited
FY 2025 filings availableAritas Pharmaceuticals Private Limited reported revenue of ₹17.3 Lakh (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year. EBITDA rose 254% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹73,642 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹21,416 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.3% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aritas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aritas Pharmaceuticals Private Limited
Aritas Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shavlesh Kumar Ravi | Director | 19 Oct 2023 | 3 Years 0 Months | Current |
| Beauty Kumari | Director | 07 Apr 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Aritas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aritas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aritas Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aritas Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Ranvir Kumar ceased to be Director on 20 Oct 2023.
Frequently asked questions
Aritas Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 07 April 2021 (5+ years old) and is registered under CIN U24299UP2021PTC144755.
Aritas Pharmaceuticals has 2 current directors:
- Shavlesh Kumar Ravi - Director
- Beauty Kumari - Director
The latest financial statements of Aritas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Aritas Pharmaceuticals is U24299UP2021PTC144755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aritas Pharmaceuticals was incorporated on 07 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ranvir Kumar ceased to be Director on 20 Oct 2023. Shavlesh Kumar Ravi was appointed as Director on 19 Oct 2023. Beauty Kumari was appointed as Director on 07 Apr 2021.
Yes, Aritas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0033758).
The registered office of Aritas Pharmaceuticals is at C12 – 0105 Supertech Eco Village 2 Gh – 01 Sec – 16B Greater Noida, Uttar Pradesh, India – 201318.
Aritas Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Aritas Pharmaceuticals can be reached at its registered office: C12 – 0105 Supertech Eco Village 2 Gh – 01 Sec – 16B Greater Noida, Uttar Pradesh, India – 201318.

